First Zantac cancer risk trial in Calif. postponed five months
By Brendan Pierson (Reuters) -The first scheduled trial over claims that GSK Plc’s heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months. The case, brought by California resident James Goetz in Alameda County Superior Court, is now expected to go to trial July 24, according to …
First Zantac cancer risk trial in Calif. postponed five months Read More »